Showing results (81-90 of 237) with videos related to

Sort By:
Pageof 24
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 20, 2007
[Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical Hematology]Akihiko Gotoh, Kazuma Ohyashiki, Kazuo Oshimi, et al.
Leukemia & Lymphoma|April 15, 2003
Natural killer cell lymphoma in the duodenumMasahiko Sumi, Tetsuzo Tauchi, Goro Sashida, et al.
Plos One|May 15, 2009
Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patientsMasami Tanaka, Kosuke Oikawa, Masakatsu Takanashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 5, 2002
[Chronic myeloid leukemia associated with sustained severe pancytopenia after imatinib mesylate therapy]Masahiko Sumi, Tetsuzo Tauchi, Takashi Shimamoto, et al.
International Journal of Hematology|December 26, 2006
Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "lung injury by bortezomib" joint committee of the Japanese society of hematology and the Japanese society of clinical hematologyAkihiko Gotoh, Kazuma Ohyashiki, Kazuo Oshimi, et al.
Cancer Biology & Therapy|October 9, 2013
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL-positive leukemia cells involves the ABL kinase domain mutationSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.
Leukemia Research|June 24, 2010
Multicenter phase II trial of vitamin K(2) monotherapy and vitamin K(2) plus 1alpha-hydroxyvitamin D(3) combination therapy for low-risk myelodysplastic syndromesNobu Akiyama, Keisuke Miyazawa, Yoshinobu Kanda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 22, 2006
[Effectiveness of long term administration of humanized anti-interleukin-6 receptor antibody (tocilizumab) for multicentric Castleman's disease with pulmonary involvement]Daigo Akahane, Yukihiko Kimura, Masahiko Sumi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 17, 2009
Effective and well tolerated treatment with melphalan and dexamethasone for primary systemic AL amyloidosis with cardiac involvementSeiichiro YOSHIZAWA, Daigo AKAHANE, Hiroaki FUJIMOTO, et al.
Blood|February 7, 2002
Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15)Takashi Fujino, Akitaka Suzuki, Yoshikazu Ito, et al.
Pageof 24